Literature DB >> 8354813

Mechanisms and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty. North American Inoue Balloon Investigators.

H C Herrmann1, J A Lima, T Feldman, R Chisholm, J Isner, W O'Neill, K Ramaswamy.   

Abstract

OBJECTIVES: The purpose of this study was to assess the incidence, mechanism and outcome of severe mitral regurgitation after treatment of mitral stenosis with percutaneous mitral valvuloplasty using the Inoue balloon.
BACKGROUND: Severe mitral regurgitation occurs in up to 15% of percutaneous balloon valvuloplasty procedures for acquired mitral stenosis. The incidence and mechanism of production of mitral regurgitation with the recently introduced single-balloon Inoue technique have not been characterized.
METHODS: We examined the incidence, mechanism, predictors and outcome of severe mitral regurgitation after Inoue balloon valvuloplasty in 280 patients in the North American multicenter registry. Twenty-one patients who developed either clinically significant or angiographically severe regurgitation were identified, and their echocardiograms were reviewed to determine the mechanism of regurgitation. These patients were then compared with the remaining patients without severe regurgitation to identify predictors of this outcome.
RESULTS: The incidence of severe regurgitation in this study was 7.5%, and the mean grade of angiographic regurgitation in these patients increased from 0.9 +/- 1.0 to 2.8 +/- 0.7 (p < 0.05). The most common cause of regurgitation (43%) was rupture of chordae tendineae to the anterior or posterior mitral leaflet. Tearing of a leaflet (usually the posterior one) occurred in 30% of patients; and no recognizable structural abnormality, with wide splitting of the commissures and a central regurgitant jet, was present in five patients (26%). All patients with definite posterior leaflet tears had heavily calcified leaflets. Patients who developed severe regurgitation had fewer balloon inflations and a higher grade of preexisting mitral regurgitation but were otherwise similar to the remaining patients without severe regurgitation. During 6-month follow-up, 71% of the patients with severe regurgitation were treated surgically; the grade of regurgitation decreased in four patients (19%), and five patients (24%) have not required mitral valve replacement during 18 +/- 5 months of follow-up.
CONCLUSIONS: Severe mitral regurgitation is a relatively infrequent complication of Inoue balloon valvuloplasty and results from disruption of the valve integrity, including chordal rupture and leaflet tearing. Careful balloon positioning may help avoid chordal rupture, and heavily calcified posterior leaflets may be at greater risk of tearing. Most patients who develop severe regurgitation will require nonemergency mitral valve replacement.

Entities:  

Mesh:

Year:  1993        PMID: 8354813     DOI: 10.1016/0735-1097(93)90191-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Balloon valvuloplasty.

Authors:  A Vahanian
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 2.  Percutaneous mitral balloon valvuloplasty.

Authors:  C E Mayes; J E Cigarroa; R A Lange; L D Hillis
Journal:  Clin Cardiol       Date:  1999-08       Impact factor: 2.882

3.  Partial papillary muscle rupture following percutaneous mitral valvuloplasty without mitral regurgitation.

Authors:  Arun Gopalakrishnan; Sanjay Ganapathi; Sivasankaran Sivasubramonian; Harikrishnan Sivadasanpillai
Journal:  J Echocardiogr       Date:  2016-02-12

4.  Mechanism and Immediate Outcome of Significant Mitral Regurgitation Following Balloon Mitral Valvuloplasty with JOMIVA Balloon.

Authors:  Shanmuga Sundaram; Tamilarasu Kaliappan; Rajendiran Gopalan; Ramasamy Palanimuthu; Premkrishna Anandhan; Rinku Mary Joseph
Journal:  J Clin Diagn Res       Date:  2017-03-01

5.  Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

Authors:  Maria Carmo P Nunes; Robert A Levine; Renato Braulio; Marcelo A Pascoal-Xavier; Sammy Elmariah; Nayana F A Gomes; Juliana R Soares; William A M Esteves; Xin Zeng; Jacob P Dal-Bianco; Livia S A Passos; Luiz G Passaglia; Victor T Ribeiro; Cláudio L Gelape; Paulo H N Costa; Lucas Lodi-Junqueira; Walderez Dutra; Timothy C Tan; Elena Aikawa; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16

6.  A differentiated morphological parameter-coding system to describe the suitability of mitral valve stenoses intended for percutaneous valvotomy.

Authors:  Nikola Bogunovic; Dieter Horstkotte; Werner Scholtz; Lothar Faber; Lukas Bogunovic; Frank van Buuren
Journal:  Heart Vessels       Date:  2014-06-27       Impact factor: 2.037

7.  Progression of Mitral Regurgitation in Rheumatic Valve Disease: Role of Left Atrial Remodeling.

Authors:  Nayana F A Gomes; Vicente Rezende Silva; Robert A Levine; William A M Esteves; Marildes Luiza de Castro; Livia S A Passos; Jacob P Dal-Bianco; Alexandre Negrão Pantaleão; Jose Luiz Padilha da Silva; Timothy C Tan; Walderez O Dutra; Elena Aikawa; Judy Hung; Maria Carmo P Nunes
Journal:  Front Cardiovasc Med       Date:  2022-03-11

8.  Proinflammatory Matrix Metalloproteinase-1 Associates With Mitral Valve Leaflet Disruption Following Percutaneous Mitral Valvuloplasty.

Authors:  Livia S A Passos; Dakota Becker-Greene; Renato Braulio; Thanh-Dat Le; Cláudio L Gelape; Luís Felipe R de Almeida; Divino Pedro A Rocha; Carlos Augusto P Gomes; William A M Esteves; Luiz G Passaglia; Jacob P Dal-Bianco; Robert A Levine; Masanori Aikawa; Judy Hung; Walderez O Dutra; Maria Carmo P Nunes; Elena Aikawa
Journal:  Front Cardiovasc Med       Date:  2022-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.